Diversified manufacturer SPX () said Q1 EPS leapt 107% to $1.14 ex items, blowing by views by 15 cents. Revenue jumped 37% to $1.39 bil, just below views. It rose 9% to 123.

Rockwood Holdings, () a specialty chemicals maker, said Q1 EPS jumped 35% to 58 cents ex items, topping estimates by 9 cents. Revenue climbed 14% to $854 mil, above views. Shares rose 0.9% to 36.91.

Amedisys, () a provider of home health care, said Q1 EPS climbed 22% to 62 cents, beating views by 4 cents. Revenue jumped 39% to $213.1 mil. It leapt 10% to 51.80.

CryoLife, () a biotech, said Q1 EPS rose 150% to 10 cents, beating views by 2 cents. Revenue grew 4% to $25.6 mil, just below forecasts. It fell 3.2% to 10.62.

For The Record: A story on April 18, “Columbia Fund Looks At Big Picture,” should have stated fund manager Emil Gjester noted that Nike is seeing its biggest revenue growth in Asia.

For The Record: An editorial on A16 Mon., “New World Order,” should have stated: In 2007, Colombia supplied 50 mil barrels of oil and Brazil supplied 61 mil small numbers compared with our biggest supplier, Canada, which sold the U.S. 680 mil barrels last year.

This entry was posted on Friday, May 16th, 2008 at 2:52 pm While Dave was in Money. Responses are currently closed, but you can trackback from your own site.